Free Newsletter
CRO adopts online regulatory publishing system
Acronym aficionados take note: CRO has sprouted the subcategory PRO, for pharmaceutical research organization.
One such company, which shall remain unnamed, has selected Mission3's Internet-based OnDemand system for client regulatory publishing worldwide. The research organization is said to be seeking to expand its services line so it can offer end-to-end client solutions.
OnDemand is "a regulatory submission authoring and publishing platform," according to a Mission3 announcement. It includes some 300 regulatory templates, web-authoring capabilities, library services, security, access control, electronic signatures, and rendering. The software platform is 21 CFR 11 compliant, the company says, and available in both Internet and SaaS versions.
- here's the announcement
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: